Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

SOBI Acquires European Rights to Dongbao Anemia Drug

publication date: Nov 4, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Swedish Orphan Biovitrum has in-licensed European marketing rights to Iron Sucrose Rechon, an anemia drug, from Dongbao Group’s subsidiary, Rechon Life Science Group, a contract manufacturer located in Malmo, Sweden. Sobi will pay a $1.7 million regulatory milestone to Rechon, plus a transfer price and a royalty on net sales. More details....

Stock Symbols: (STO: SOBI) (SHEX: 600867)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners